Diagnostics group adds $21M in second VC round

The UK's Abingworth led the second round for Primera Biosystems, helping pull in $21 million for the molecular diagnostics company. InterWest Partners joined with Malaysian Technology Development, MPM Capital, Burrill & Co. and the Invus Group in the round. Primera gained $11 million in its first round two years ago and has been developing new technology related to gene expression, DNA/RNA analysis, micro RNA analysis, mutation analysis and methylated DNA analysis.

- see Primera's release on the round
- here's the report on the round from MassHighTech

Suggested Articles

Xevinapant in combination with standard cisplatin-based chemoradiation therapy (CRT) reduces the risk of death in high-risk patients with locally adva

Ironwood had once hyped this drug as a $2 billion-a-year asset, but IW-3718 has failed to live up to its high expectations.

Junshi’s PD-1 blocker is already approved in China for metastatic melanoma, but the Shanghai-based biotech may soon add throat cancer to its label.